Breaking News, Collaborations & Alliances

DelMar Pharma, Guangxi Wuzhou Establish Advisory Board in China

To oversee clinical studies aimed at expanding DAG market

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

DelMar Pharmaceuticals, Inc. and Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. have established a clinical advisory board to oversee clinical studies aimed at expanding the market for VAL-083, known as DAG for Injection in China.   The companies established a collaboration and exclusive supply agreement in 2012 to help ensure the product specifications meet global standards to accelerate international development and regulatory approval for VAL-083 on a worldwide basis.   “Guangxi Wuzhou ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters